drugset / Trial / NCT01190826
Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and clinical activity of ASM-024 in stable moderate asthma.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-12
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASM-024 | Unknown | 10 mg | Inhaled |
| Subject | ASM-024 | Unknown | 100 mg | Inhaled |